| __timestamp | Pharming Group N.V. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 13774000 |
| Thursday, January 1, 2015 | 5279557 | 22479000 |
| Friday, January 1, 2016 | 8073913 | 27388000 |
| Sunday, January 1, 2017 | 44864073 | 35610000 |
| Monday, January 1, 2018 | 53488904 | 49007000 |
| Tuesday, January 1, 2019 | 65896361 | 61139000 |
| Wednesday, January 1, 2020 | 69968267 | 68836000 |
| Friday, January 1, 2021 | 92047281 | 97592000 |
| Saturday, January 1, 2022 | 131819000 | 106903000 |
| Sunday, January 1, 2023 | 87501000 | 120998000 |
Unleashing insights
In the ever-evolving biotech industry, understanding financial trends is crucial for investors and stakeholders. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of two prominent companies: Pharming Group N.V. and Vericel Corporation, from 2014 to 2023. Over this period, Vericel Corporation's SG&A expenses surged by approximately 780%, peaking in 2023, while Pharming Group N.V. saw a more modest increase of around 2,065%, with its highest expenses recorded in 2022. Notably, both companies experienced significant growth in their SG&A costs, reflecting their strategic investments in marketing and administration to support expansion. The data highlights a competitive landscape where efficient cost management could be a key differentiator. As the biotech sector continues to grow, monitoring these financial metrics will be essential for predicting future performance and making informed investment decisions.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends